14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
IDE vs JRI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
JRI Overall Winner
6-Pillar Tally: IDE 0 – 1 JRI (5 Tie)
Matrix Metrics: IDE 1 – 3 JRI
As of Nov 16, 2026, Nuveen Real Asset Income And Growth Fund (JRI) is the stronger overall head-to-head candidate over Voya Infrastructure, Industrials And Materials Fund (IDE) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). IDE carries a Unified Composite Score of 49.7/100 (HOLD) at $11.75 (N/M Forward P/E, N/A operating margin), whereas JRI carries 39.7/100 (SELL) at $11.09 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While IDE currently prints a higher short-term Unified Composite Score (49.7/100 HOLD vs. JRI 39.7/100 SELL), JRI captures the overall institutional head-to-head verdict (3–1 matrix metrics and 1–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: IDE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.5); meanwhile JRI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IDE vs JRI. Trailing 12-month operating profitability (IDE N/A vs JRI N/A) and valuation multiples (IDE N/M vs JRI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with $392.9M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ IDE vs JRI Key Questions & Quantitative Answers
As of Nov 16, 2026, Nuveen Real Asset Income And Growth Fund (JRI) is the stronger overall head-to-head candidate over Voya Infrastructure, Industrials And Materials Fund (IDE) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). IDE carries a Unified Composite Score of 49.7/100 (HOLD) at $11.75 (N/M Forward P/E, N/A operating margin), whereas JRI carries 39.7/100 (SELL) at $11.09 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While IDE currently prints a higher short-term Unified Composite Score (49.7/100 HOLD vs. JRI 39.7/100 SELL), JRI captures the overall institutional head-to-head verdict (3–1 matrix metrics and 1–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: IDE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.5); meanwhile JRI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
JRI leads the Growth & Scale pillar: IDE posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with JRI at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, IDE generates N/A in USD-normalized revenue versus N/A for JRI. In operating R&D and SG&A reinvestment, IDE deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for JRI.
IDE and JRI trade at balanced relative valuation multiples. IDE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas JRI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IDE (N/A ROE) versus JRI (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, IDE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.86β · 24% Vol realized risk). By comparison, JRI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.51β · 22% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.